DDInter819 DDInter105
_Ginkgo biloba_ extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties. Most of the studies that investigate the effect of _ginkgo biloba_ use the standardized extract of _Ginkgo biloba_ (EGb) 761 (EGb761), which was developed by a German pharmaceutical company in 1964. EGb761 contains 6% terpene lactones and 24% flavonoid glycosides. Flavonoids include quercetin, rutin, kaempferol, and isorhamnetin. Lactones include ginkgolide A, ginkgolide B, ginkgolide C, bilobalide, and
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
Ginkgo biloba {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Clopidogrel
Ginkgo biloba {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Enzalutamide
Ginkgo biloba may cause a moderate interaction that could exacerbate diseases when taken with Clopidogrel
Ginkgo biloba may cause a moderate interaction that could exacerbate diseases when taken with Enzalutamide